Rocket Pharmaceuticals (RCKT) EBIT (2014 - 2026)
Rocket Pharmaceuticals (RCKT) reported EBIT of -$48.5 million for Q1 2026, up 24.66% on a YoY basis from -$38.9 million in Q1 2025, and down 10.35% sequentially from -$44.0 million in Q4 2025.
Rocket Pharmaceuticals (RCKT) EBIT (2014 - 2026) Analysis & Trends
Rocket Pharmaceuticals (RCKT) has 13 years of EBIT data on file, last reported at -$48.5 million in Q1 2026.
- For the quarter ending Q1 2026, EBIT rose 24.66% year-over-year to -$48.5 million; the trailing twelve-month figure through Mar 2026 stood at -$215.9 million (up 20.11% YoY), and the FY2025 full-year result was -$231.7 million, up 15.17% from the prior year.
- EBIT eased to -$48.5 million in Q1 2026, from -$44.0 million in the prior quarter.
- In the past five years, EBIT ranged from a high of -$42.6 million in Q1 2022 to a low of -$73.7 million in Q2 2024.
- A 5-year average of -$61.0 million and a median of -$63.3 million in 2023 frame the typical range for EBIT.
- Across the five-year window, EBIT tumbled 59.22% in 2022 and advanced 29.88% in 2025, its largest moves.
- Tracing RCKT's EBIT over 5 years: stood at -$69.1 million in 2022, then advanced by 8.4% to -$63.3 million in 2023, then rose by 0.92% to -$62.7 million in 2024, then increased by 29.88% to -$44.0 million in 2025, then retreated by 10.35% to -$48.5 million in 2026.
- Business Quant data shows RCKT's EBIT at -$48.5 million in Q1 2026, -$44.0 million in Q4 2025, and -$52.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 394.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -445.22 Mn |
| 10 | Rocket Pharmaceuticals | 359.39 Mn | 359.39 Mn | - | -48.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -48.51 Mn |
| Dec 31, 2025 | -43.96 Mn |
| Sep 30, 2025 | -52.25 Mn |
| Jun 30, 2025 | -71.15 Mn |
| Mar 31, 2025 | -64.39 Mn |
| Dec 31, 2024 | -62.69 Mn |
| Sep 30, 2024 | -69.42 Mn |
| Jun 30, 2024 | -73.71 Mn |
| Mar 31, 2024 | -67.38 Mn |
| Dec 31, 2023 | -63.28 Mn |
| Sep 30, 2023 | -65.43 Mn |
| Jun 30, 2023 | -68.76 Mn |
| Mar 31, 2023 | -62.19 Mn |
| Dec 31, 2022 | -69.08 Mn |
| Sep 30, 2022 | -58.49 Mn |
| Jun 30, 2022 | -54.21 Mn |
| Mar 31, 2022 | -42.56 Mn |
| Dec 31, 2021 | -44.33 Mn |
| Sep 30, 2021 | -49.65 Mn |
| Jun 30, 2021 | -34.05 Mn |